According to the above basic theory, Marampon et al. used the MEK/ERK inhibitor U0126 and embryonal rhabdomyosarcoma cell line-xenotransplanted mice to verify whether MEK//ERK inhibitions affect C-Myc protein level and growth of RMS tumor. This evidence concerns the gene MAP2K7 and neoplasm.